GLUCOSE MONITOR RESTRICTIONS MAY BE TROUBLESOME

APRIL 01, 2006

The results of a new study released
by the National Association of Chain
Drug Stores (NACDS) predict problems
ahead for Medicare beneficiaries
with diabetes if blood glucose monitors
and related testing supplies are
included in the new Medicare competitive
acquisition program scheduled
to start in 2007.

The study, conducted for the chain
drug industry group by Health Policy
R&D, raises particular concerns about
the ability of pharmacies to continue
to supply blood glucose monitors
under the new program. These monitors,
which NACDS called "an integral
part of disease management for
patients with diabetes," are currently
covered under the durable medical
equipment benefit in Medicare Part B.

Shifting glucose monitors and supplies
to the competitive bidding system
"could create a situation where
Medicare beneficiaries with diabetes
might be unable to access all
aspects of their glucose management
regimenincluding their medications,
monitors, supplies, and
related professional servicesfrom
their community pharmacy of
choice," NACDS said.

"CMS [Centers for Medicare &
Medicaid Services] needs to be
aware that competitive bidding for
blood glucose meters and related
supplies under Medicare Part B
could potentially do more harm than
good for beneficiaries," NACDS
Senior Vice President Mary Ann
Wagner said.